Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer

Annals of Internal Medicine

Volumn 130, Issue 4 I, 1999, Pages 270-277

  Cauley, Jane A ^a   Lucas, Frances L ^b   Kuller, Lewis H ^a   Stone, Katie ^c   Browner, Warren ^c   Cummings, Steven R ^c  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b MAINE MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; TESTOSTERONE;

AGED; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

EID: 0033573946     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-130-4_part_1-199902160-00004     Document Type: Article

References (51)

1. Miller BA, Feuer EJ, Hankey BF. The significance of the rising incidence of breast cancer in the United States. Important Adv Oncol. 1994;193-207.
2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin. 1997;47:5-27.
3. Colditz GA. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst. 1998;90:814-23.
4. Toniolo PG, Levitz M, Zeleniuch-jacquotte A, Banerjee S, Koenig KL, Shore RE, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst. 1995;87:190-7.
5. Dorgan JF, Longcope C, Stephenson HE Jr, Falk RT, Miller R, Franz C, et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1996;5:533-9.
6. Moore JW, Clark GM, Hoare SA, Millis RR, Hayward JL, Quinlan MK, et al. Binding of oestradiol to blood proteins and aetiology of breast cancer. Int J Cancer. 1986;38:625-30.
7. Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, et al. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst. 1996;88:291-6.
8. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 1998;90:1292-9.
9. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev. 1994;18:79-85.
10. Garland CF, Friedlander NJ, Barrett-Connor E, Khaw KT. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am J Epidemiol. 1992;135:1220-30.
11. Wysowski DK, Comstock GW, Helsing KJ, Lau HL. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol. 1987;125:791-9.
12. Bulbrook RD, Moore JW, Clark GM, Wang DY, Millis RR, Hayward JL. Relation between risk of breast cancer and biological availability of estradid in the blood: prospective study in Guernsey. Ann N Y Acad Sci. 1986;464:378-88.
13. Thomas HV, Reeves GK, Key TJ. Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control. 1997;8:922-8.
14. Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA. 1996;276:1404-8.
15. Zhang Y, Kiel DP, Kreger BE, Cupples LA, Ellison RC, Dorgan JF, et al. Bone mass and the risk of breast cancer among postmenopausal women. M Engl J Med. 1997;336:611-7.
16. Meema S, Meema HE. Possible estrogenic effect on bone in postmenopausal patients with mammary carcinoma. Cancer. 1966;19:433-6.
17. Dorgan JF, Stanczyk FZ, Longcope C, Stephenson HE Jr, Chang L, Miller R, et al. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 1997;6:177-81.
18. Zeleniuch-Jacquotte A, Bruning PF, Bonfrer JM, Koenig KL, Shore RE, Kim MY, et al. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am J Epidemiol. 1997;145:1030-8.
19. Thomas HV, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman IS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menooausal women on the island of Guernsey. Br J Career. 1997;76:401-5.
20. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-88.
21. Cummings SR, Eckert S, Grady D, Glusman J, Krueger K, Norton L, et al. Raloxifene reduces the risk of breast cancer in postmenopausal women with osteoporosis. [Abstract]. Proceedings of the American Society of Clinical Oncology Program. May 1998.
22. Evista (package insert). Indianapolis, IN: Eli Lilly; 1998.
23. Cummings SR, Black DM, Nevitt MC, Browner WS, Cauley JA, Genant HK, et al. Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA. 1990;263:665-8.
24. Prentice RL. A case-control design for epidemiologic cohort studies and disease prevention trials. Biometrika. 1986;73:1-11.
25. Schatzkin A, Jones DY, Hoover RN, Taylor PR, Brinton LA, Ziegler RG, et al. Alcohol consumption and breast cancer in the epidemiologic follow-up study of the first National Health and Nutrition Examination Survey. N Engl J Med. 1987;316:1169-73.
26. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE. Moderate alcohol consumption and the risk of breast cancer N Engl J Med. 1987;316:1174-80.
27. SEER Cancer Statistics Review, 1973-1990. Bethesda, MD: U.S. Department of Health and Human Services; 1993. National Institutes ol Health publication no. 93-2789.
28. Kelsey JL, Bernstein L. Epidemiology and prevention of breast cancer. Annu Rev Public Health. 1996;17:47-67.
29. Rose DP, Connolly JM, Chlebowski RT, Buzzard IM, Wynder EL. The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Res Treat. 1993;27: 253-62.
30. Dorgan JF, Reichman ME, Judd JT, Brown C, Longcope C, Schatzkin A, et al. Relation of energy, fat, and fiber intakes to plasma concentrations of estrogens and androgens in premenopausal women. Am J Clim Nutr. 1996;64:25-31.
31. Prentice R, Thompson D, Clifford C, Gorbach S, Goldin B, Byar D. Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. The Women's Health Trial Study Group. J Natl Cancer Inst. 1990;82:129-34.
32. de Waard F, Poortman J, de Pedro-Alvarez Ferrero M, Baanders-van Halewijn EA. Weight reduction and oestrogen excretion in obese postmenopausal women. Maturitas. 1982;4:155-62.
33. Armstrong BK, Brown JB, Clarke HT, Crooke DK, Hahnel R, Masarei JR, et al. Diet and reproductive hormones: a study of vegetarian and non-vegetarian postmenopausal women. J Natl Cancer Inst. 1981;67:761-7.
34. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol. 1989; 129:1120-31.
35. Design of the Women's Health Initiative: clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998;19:61-109.
36. Maclndoe JH, Etre LA. An antiestrogenic action of androgens in human breast cancer cells. J Clin Endocrinol Metab. 1981;53:836-42.
37. Jaffe RB. Pathophysiology: the menopause and penmenopausal period. In: Yen SS, Jaffe RB, eds. Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management. 2d ed. Philadelphia: WB Saunders; 1986:406-23.
38. O'Neill JS, Miller WR. Aromatase activity in breast adipose tissue from women with benign and malignant breast diseases. Br J Cancer. 1987;56:601-4.
39. Santen RJ, Leszczynski D, Tilson-Mallet N, Feil PD, Wright C, Manni A, et al. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways. Ann N Y Acad Sci. 1986;464: 126-37.
40. Thijssen JH, Blankenstein MA, Donker GH, Daroszewski J. Endogenous steroid hormones and local aromatase activity in the breast J Steroid Biochem Mol Biol. 1991;39:799-804.
41. Perel E, Wilkins D, Killinger DW. The conversion of androstenedione to estrone, estradiol, and testosterone in breast tissue. J Steroid Biochem. 1980; 13:89-94.
42. Spratt JS, Meyer JS, Spratt JA. Rates of growth of human neoplasms: Part II. J Surg Oncol. 1996;61:68-83.
43. Blankenstein MA, Maitimu-Smeele I, Donker GH, Daroszewski J, Milewicz A, Thijssen JH. On the significance of in situ production of oestrogens in human breast cancer tissue. J Steroid Biochem Mol Biol. 1992;41:891-6.
44. Sellers TA, Gapstur SM, Potter JD, Kushi LH, Bostick RM, Folsom AR. Association of body fat distribution and family histories of breast and ovarian cancer with risk of postmenopausal breast cancer. Am J Epidemiol. 1993;138: 799-803.
45. Mannisto S, Pietinen P, Pyy M, Palmgren J, Eskelinen M, Uusitupa M. Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status. Int J Cancer. 1996;68:8-13.
46. Killinger DW, Perel E, Daniilescu D, Kharlip L, Lindsay WR. The relationship between aromatase activity and body fat distribution Steroids. 1987; 50:61-72.
47. Rink JD, Simpson ER, Barnard JJ, Bulun SE. Cellular characterization of adipose tissue from various body sites of women. J Clin Endocrinol Metab. 1996;81:2443-7.
48. Rockhill B, Weinberg CR, Newman B. Population attributable fraction estimation for established breast cancer risk factors: considering the issues of high prevalence and unmodifiability. Am J Epidemiol 1998;147:826-33.
49. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev. 1996;4:649-54.
50. Kuller LH, Gutai JP, Meilahn E, Matthews KA, Plantinga P. Relationship of endogenous sex steroid hormones to lipids and apoproteins in postmenopausal women. Arteriosclerosis. 1990;10:1058-66.
51. Muti P, Trevisan M, Micheli A, Krogh V, Bolelli G, Sciajno R, et al. Reliability of serum hormones ir premenopausal and postmenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev. 1996;5917-22.